Brophebarbital
Brophebarbital is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which make it useful in the treatment of insomnia and other sleep disorders. Brophebarbital is chemically related to other barbiturates such as phenobarbital and pentobarbital.
Chemical Structure and Properties[edit | edit source]
Brophebarbital belongs to the class of organic compounds known as barbiturates. These compounds are derivatives of barbituric acid and are characterized by their ability to depress the central nervous system. The chemical structure of brophebarbital includes a pyrimidine ring, which is a common feature of barbiturates.
Pharmacology[edit | edit source]
Brophebarbital acts on the gamma-aminobutyric acid (GABA) receptor, enhancing the effect of the neurotransmitter GABA. This action results in increased inhibitory neurotransmission, leading to sedation and hypnosis. The drug has a relatively long half-life, which makes it effective for maintaining sleep throughout the night.
Medical Uses[edit | edit source]
Brophebarbital is primarily used for its sedative and hypnotic effects. It is prescribed for the short-term treatment of insomnia and is sometimes used as a pre-anesthetic agent. Due to its potential for dependence and tolerance, it is generally recommended for short-term use only.
Side Effects and Risks[edit | edit source]
Common side effects of brophebarbital include drowsiness, dizziness, and headache. More serious side effects can include respiratory depression, hypotension, and allergic reactions. Long-term use can lead to dependence and withdrawal symptoms upon discontinuation.
Regulation and Legal Status[edit | edit source]
Brophebarbital, like other barbiturates, is a controlled substance in many countries due to its potential for abuse and dependence. It is classified under various schedules depending on the jurisdiction.
History[edit | edit source]
Brophebarbital was first synthesized in the early 20th century as part of the search for new sedative and hypnotic agents. It was one of many barbiturates developed during this period, which also saw the introduction of other well-known compounds such as phenobarbital and secobarbital.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD